CMV-vector vaccine (TomegaVax)

N/A

Report date: 2025/01/26 19:05:20

Base Information

Drug NameCMV-vector vaccine (TomegaVax)
Drug Alias Namecytomegalovirus-vector vaccine (TomegaVax)
ClassificationVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHerpes Simplex Virus Type 2 Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTomegavax Inc
China Registration ClassN/A

Develop Information

Active CompaniesTomegavax Inc
Inactive CompaniesN/A
Active IndicationsHerpes Simplex Virus Type 2 Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A